Narrow Your Results

Strategy

Sections

Showing 1 - 2 of 2 Results for "prevention"

Results

Malaria Gap
Further studies are needed to determine whether standard intermittent preventive treatment and antiretroviral therapy regimens are medically and operationally compatible in pregnancy and to determine safe and effective protocols for management of concurrent HIV and malarial infections in pregnant and non-pregnant women living with HIV. A study found that alternative malarial drug regimens should be considered for HIV/malaria co-infected patients receiving nevirapine.
Malaria
1 study
Alternate efficacious drugs for intermittent preventive treatment are needed due to resistance to SP. In Tanzania, a country with high rates of SP resistance, SP during pregnancy increased the risk of fetal anemia and decreased cord hemoglobin levels. IPTp did not decrease the risk of placental malaria, maternal anemia, or low birth weight. (Harrington et al., 2011).
Malaria
1 study